Drugs Made In America Acquisition II Corp.
DMII
$9.92
$0.050.51%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7,061.36% | -37.14% | |||
| Total Receivables | 21,680.77% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 226.09% | 0.00% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 7,627.59% | 0.00% | |||
|
|
|||||
| Total Current Assets | 7,627.59% | 0.00% | |||
| Net Property, Plant & Equipment | -- | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 491,166.60% | 8.88% | |||
| Total Assets | 441,703.97% | 7.90% | |||
|
|
|||||
| Total Accounts Payable | -- | -- | |||
| Total Accrued Expenses | 163.64% | -80.53% | |||
| Short-term Debt | -- | 18.87% | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | 2,273.31% | 41.92% | |||
| Total Other Current Liabilities | 2,273.31% | 41.92% | |||
| Total Current Liabilities | 106.81% | 16.51% | |||
|
|
|||||
| Total Current Liabilities | 106.81% | 16.51% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | 18.87% | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 158,155.48% | 16.51% | |||
|
|
|||||
| Common Stock & APIC | -95.43% | 0.00% | |||
| Retained Earnings | -6,837.98% | -18.06% | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -7,971.46% | -21.65% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -7,971.46% | -21.65% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -7,971.46% | -21.65% | |||
|
|
|||||